Severity and prognosis of acute human immunodeficiency virus type 1 illness: A dose-response relationship

Clinical Infectious Diseases

Volumn 26, Issue 2, 1998, Pages 323-329

  Vanhems, Philippe ^a   Lambert, Jean ^b   Cooper, David A ^b   Perrin, Luc ^b   Carr, Andrew ^b   Hirschel, Bernard ^b   Vizzard, Jeanette ^b   Kinloch De Loës, Sabine ^b   Allard, Robert ^b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SEROCONVERSION; SURVIVAL RATE; VIRUS LOAD;

EID: 0031905322     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516289     Document Type: Article

References (24)

1. Pedersen C, Lindhardt BØ, Jensen BL, et al. Clinical course of primary HIV infection: consequences for subsequent course of infection. BMJ 1989;299:154-7.
2. Schechter MT, Craib KJP, Le TN, et al. Susceptibility to AIDS progression appears early in HIV infection. AIDS 1990;4:185-90.
3. Sinicco A, Fora R, Sciandra M, Lucchini A, Caramello P, Gioannini P. Risk of developing AIDS after primary acute HIV-1 infection. J Acquir Immune Defic Syndr 1993;6:575-81.
4. Dorrucci M, Rezza G, Vlahov D, et al. Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. AIDS 1995;9:597-604.
5. Keet IPM, Krijnen P, Koot M, et al. Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS 1993;7:51-7.
6. 6/1, AIDS, and death from AIDS? BMJ 1994;309:1535-7.
7. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41 (suppl RR-17):1-19.
8. Rabeneck L, Crane MM, Risser JMH, Lacke CE, Wray NP. A simple clinical staging system that predicts progression to AIDS using CD4 count, oral thrush, and night sweats. J Gen Intern Med 1993;8:5-9.
9. Lifson AR, Hilton JF, Westenhouse JL, et al. Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts. AIDS 1994;8:73-9.
10. Greenspan D, Greenspan JS, Overby G, et al. Risk factors for rapid progression from hairy leukoplakia to AIDS: a nested case-control study. J Acquir Immune Defic Syndr 1991;4:652-8.
11. Sydney AIDS Study Group. The Sydney AIDS project. Med J Aust 1984;141:569-73.
12. Veugelers PJ, Page KA, Tindall B, et al. Determinants of HIV disease progression among homosexual men registered in the tricontinental seroconverters study. Am J Epidemiol 1994;140:747-58.
13. Vanhems P, Allard R, Cooper DA, et al. Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive? Clin Infect Dis 1997;24:965-70.
14. Ledergeber B, von Overbeck J, Egger M, Lüthy R. The Swiss HIV Cohort Study: rationale, organization and selected baseline characteristics. Soz Praventivmed 1994;39:387-94.
15. Kinloch-de Loës S, Hirschel BJ, Hoen B, et al. A controlled trial of zidovudine in primary human immunodeficiency virus infection. N Engl J Med 1995;333:408-13.
16. Kaldor J, McDonald AM, Blumer CE, et al. The acquired immunodeficiency syndrome in Australia: incidence 1982-1991. Med J Aust 1993;158:10-7.
17. Lee ET, ed. Nonparametric methods for comparing survival distributions. In: Statistical methods for survival data analysis. 2nd ed. New York: John Wiley & Sons, 1992:104-30.
18. Lee ET, ed. Identification of prognostic factors related to survival time. In: Statistical methods for survival data analysis. 2nd ed. New York: John Wiley & Sons, 1992:243-80.
19. Niu MT, Stein DS, Schnittman SM. Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment intervention in human and animal retrovirus infections. J Infect Dis 1993;168:1490-501.
20. Zaunders J, Carr A, McNally L, Penny R, Cooper DA. Effects of primary HIV-1 infection on subsets of CD4+ and CD8+ T lymphocytes. AIDS 1995;9:561-6.
21. Mellors JW, Kingsley LA, Rinaldo CR Jr, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-9.
22. Amadori A, Zamarchi R, De Silvestro G, et al. Genetic control of the CD4/CD8 T-cell ratio in humans. Nature Med 1995;1:1279-83.
23. Kaslow RA, Carrington M, Apple R, et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature Med 1996;2:405-11.
24. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-62.